NCT04093050

Safety and Pharmacokinetics of Vasopressin in Healthy Volunteers

A Phase 1, Open-Label, Two-Arm, Parallel-Group, Pharmacokinetic Study on Plasma Clearance of Vasopressin in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 41 (actual)
• Sponsor: Endo Pharmaceuticals · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

Open-label Phase I pharmacokinetic (PK) study of Vasostrict® (vasopressin injection, USP) in healthy volunteers.

Conditions

• Healthy Volunteer Safety Study

Interventions

Type	Name	Description
DRUG	Vasostrict Injectable Product	Vasostrict® (vasopressin injection, USP)

Timeline

• Start date: 2019-10-10
• Primary completion: 2021-04-08
• Completion: 2021-04-11
• First posted: 2019-09-17
• Last updated: 2021-05-19

Locations

2 sites across 1 country: United States

Regulatory

• FDA-regulated drug study